pRSET A, B, & C Bacterial Expression Vectors
Product Image
Invitrogen™

pRSET A, B, & C Bacterial Expression Vectors

pRSETベクターは、強力なバクテリオファージT7プロモーターによって制御される高レベルの原核生物発現用に設計されています。発現は、BL21(DE3)大腸菌でT7 RNAポリメラーゼを生成することで誘発されます。また、これらの細胞はターゲット遺伝子の定常発現を低減するためにT7リゾチームも生成します。pRSETベクターには以下の特長があります。•高レベル発現用のバクテリオファージT7プロモーター• タンパク質の安定性をもたらすT7遺伝子の10配列•詳細を見る
製品番号(カタログ番号)数量
V3512020 μg
製品番号(カタログ番号) V35120
価格(JPY)
89,900
Online offer
Ends: 27-Mar-2026
128,500
割引額 38,600 (30%)
20 µg
お問い合わせください ›
数量:
20 μg
pRSETベクターは、強力なバクテリオファージT7プロモーターによって制御される高レベルの原核生物発現用に設計されています。発現は、BL21(DE3)大腸菌でT7 RNAポリメラーゼを生成することで誘発されます。また、これらの細胞はターゲット遺伝子の定常発現を低減するためにT7リゾチームも生成します。pRSETベクターには以下の特長があります。

•高レベル発現用のバクテリオファージT7プロモーター
• タンパク質の安定性をもたらすT7遺伝子の10配列
• ニッケルキレート樹脂を使用した迅速な浄化と抗HisG抗体による検出のためのN末端ポリヒスチジン(6xHis)タグ
• 抗Xpress™抗体による検出用のN末端Xpress™エピトープ
• 融合タグを除去するためのエンテロキナーゼ切断部位

3つのベクターセット(A、B、C)が提供されます。各ベクターには、複数のクローニング部位に関連するそれぞれの測定フレーム内にN末端タグコーディング配列があり、遺伝子のフレーム内クローニングを簡素化します。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
抗生物質耐性菌アンピシリン(AmpR)
切断EK(エンテロキナーゼ)認識部位
構成または誘導システム誘導型
誘導試薬IPTG
製品タイプ細菌発現ベクター
数量20 μg
選択剤(真核生物)なし
ベクターpRSET
クローニング法制限酵素/MCS
プロモーターT7
タンパク質タグHisタグ(x 6)
Unit Size20 µg
組成および保存条件
それぞれ20µgのpRSET A、B、およびCベクターは凍結乾燥されて提供されます。TOP10F´、BL21(DE3)pLysS、およびBL21 pRSET/lacZコントロール大腸菌スタブも含まれています。大腸菌スタブは2~8℃で保管してください。すべてのコンポーネントは、適切に保存した場合、6カ月間安定しています。

よくあるご質問(FAQ)

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

引用および参考文献 (118)

引用および参考文献
Abstract
Molecular cloning and functional reconstitution of a urate transporter/channel.
Authors:Leal-Pinto E,Tao W,Rappaport J,Richardson M,Knorr BA,Abramson RG
Journal:The Journal of biological chemistry
PubMed ID:8995305
The active conformation of avilamycin A is conferred by AviX12, a radical AdoMet enzyme.
Authors:Boll R,Hofmann C,Heitmann B,Hauser G,Glaser S,Koslowski T,Friedrich T,Bechthold A
Journal:The Journal of biological chemistry
PubMed ID:16537546
Mutational analysis of a fatty acyl-coenzyme A synthetase signature motif identifies seven amino acid residues that modulate fatty acid substrate specificity.
Authors:Black PN,Zhang Q,Weimar JD,DiRusso CC
Journal:The Journal of biological chemistry
PubMed ID:9030548
The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits.
Authors:Terry-Lorenzo Ryan T; Carmody Leigh C; Voltz James W; Connor John H; Li Shi; Smith F Donelson; Milgram Sharon L; Colbran Roger J; Shenolikar Shirish;
Journal:J Biol Chem
PubMed ID:12016225
Neurabins are protein phosphatase-1 (PP1) targeting subunits that are highly concentrated in dendritic spines and post-synaptic densities. Immunoprecipitation of neurabin I and neurabin II/spinophilin from rat brain extracts sedimented PP1gamma1 and PP1alpha but not PP1beta. In vitro studies showed that recombinant peptides representing central regions of neurabins also preferentially bound ... More
Unusual binding properties of the SH3 domain of the yeast actin-binding protein Abp1: structural and functional analysis.
Authors: Fazi Barbara; Cope M Jamie T V; Douangamath Alice; Ferracuti Silvia; Schirwitz Katja; Zucconi Adriana; Drubin David G; Wilmanns Matthias; Cesareni Gianni; Castagnoli Luisa;
Journal:J Biol Chem
PubMed ID:11668184
'Abp1p is an actin-binding protein that plays a central role in the organization of Saccharomyces cerevisiae actin cytoskeleton. By a combination of two-hybrid and phage-display approaches, we have identified six new ligands of the Abp1-SH3 domain. None of these SH3-mediated novel interactions was detected in recent all genome high throughput ... More